FindTrial
Sign In

To study the effect of pilocarpin 1.25% for treatment of presbyopia

PILocarpin 1.25% Efficacy for management of Uncorrected Presbyopia - PILE-UP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/057105
Enrollment
30
Registered
2023-08-30
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H524- Presbyopia

Interventions

Intervention1: Pilocarpine 1.25%: Pilocarpine 1.25% eye drops one time in morning (9 a.m.) for 1 month. Control Intervention1: Nil: Nil

Sponsors

Hoya surgical optics
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Presbyopic patients

Exclusion criteria

Exclusion criteria: Any ocular disorder

Design outcomes

Primary

MeasureTime frame
Distance corrected near visual acuityTimepoint: baseline, 1 month—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Namrata Sharma

Dr R P Centre for Ophthalmic sciences

namrata.sharma@gmail.com9810856988

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026